SCHEMBL6822516

SCHEMBL6822516

Cc1c(-c2ccccc2)n[nH]c1C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.69
▸ LMNA P02545 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ PKM P14618 1/20 0.51
▸ KDM4E B2RXH2 4/20 0.47
▸ ALDH1A1 P00352 4/20 0.46
▸ SLC6A3 Q01959 1/20 0.46
▸ KCNH2 Q12809 1/20 0.46
▸ TAAR1 Q96RJ0 1/20 0.46
▸ MAP2K4 P45985 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ PDE10A Q9Y233 1/20 0.45
▸ ATM Q13315 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HPGDS O60760 1/20 0.44
▸ ALPL P05186 2/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638325 0.86 RAB9A (0.70) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL5317383 0.85 HDAC6 (0.56) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL11071707 0.83 RAB9A (0.51) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL27321802 0.81 RAB9A (0.63) RAB9ALMNAMAPTSMN1; SMN2KDM4E
SCHEMBL5937211 0.81 RAB9A (0.49) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL31412684 0.80 RAB9A (0.48) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL8842823 0.80 RAB9A (0.50) RAB9ALMNAMAPTSMN1; SMN2MEN1
SCHEMBL3491623 0.80 RAB9A (0.50) RAB9ALMNAMAPTMEN1KMT2A
SCHEMBL17966223 0.80 ALDH1A1 (0.59) RAB9ALMNAMAPTSMN1; SMN2KDM4E
SCHEMBL28742838 0.80 RAB9A (0.48) RAB9ALMNAMAPTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112209878-B Cannabinoid receptor light-operated ligand and preparation method and application thereof 上海科技大学 2022-07-05 — — CN disclosed
CN-112209878-A Cannabinoid receptor light-operated ligand and preparation method and application thereof 上海科技大学 2021-01-12 — — CN disclosed
CN-103596567-B Pyrazole derivatives HOFFMAN-LA ROCHE LTD. (CH) 2016-03-16 — — CN disclosed
EP-2717873-B1 PYRAZOLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-07-15 — — EP disclosed
US-9073911-B2 Pyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2015-07-07 — — US disclosed
EP-2717873-A1 PYRAZOLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2014-04-16 — — EP disclosed
CN-103596567-A Pyrazole derivatives HOFFMANN LA ROCHE 2014-02-19 — — CN disclosed
US-20120316172-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-12-13 — — US disclosed
WO-2012168260-A1 PYRAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-12-13 — — WO disclosed
WO-2004018428-A1 ANTIBACTERIAL BENZOIC ACID DERIVATIVES PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120316172-A1 PYRAZOLE DERIVATIVES TAAR1, TAAR5, NPY1R RAB9A 1480/4885LMNA 3742/4885MAPT 230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback